ReviewDiscover nano2026
Plasmonic and surface-enhanced Raman nanobiosensors for quantitative molecular detection.
Review in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Plasmonic surface-enhanced Raman scattering (SERS) nanobiosensors employ nanoscale electromagnetic field amplification to achieve ultrasensitive, multiplex molecular detection. This review systematically outlines the fundamental plasmonic principles, nanostructure engineering strategies, and surface chemical functionalization approaches that dictate sensor performance. Quantitative analysis methodologies-including internal standards, ratio-based quantification, and machine learning-driven spectral interpretation-are critically examined. Potential clinical and field applications are highlighted through examples involving nucleic acids, proteins, pathogens, and environmental toxicants. Key technical challenges, such as reproducibility, scalable manufacturing, and methodological standardization, are discussed in detail. Finally, future directions are proposed, emphasizing single-molecule quantification, in vivo SERS applications, and the integration of sustainable materials into sensor design.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.